DSGN
NASDAQ · Biotechnology
Design Therapeutics Inc
$10.73
+0.42 (+4.07%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+449.4% upside
Low Target
$40.84
Average Target
$58.95
High Target
$77.34
Current Price
$10.73
Current
$10.73
$10.73
Target
$58.95
$58.95
$40.84
$58.95 avg
$77.34
Scenario Analysis
Bear Case
$40.84
280.6%
Low target
Base Case
$58.95
+449.4%
Avg target
Bull Case
$77.34
+620.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$11.23
-4.5% from high
52-Week Low
$2.60
+312.7% from low
Target vs 52W High
$58.95
+424.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |